MBFW
REGN icon

Morton Brown Family Wealth’s Regeneron Pharmaceuticals REGN Stock Holding History

Morton Brown Family Wealth’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$624 Buy
+1
New +$681 ﹤0.01% 348
2023
Q2 		– Sell
-3
Closed -$2.46K – 263
2023
Q1 		$2.46K Buy
+3
New +$2.26K ﹤0.01% 181

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
VF
Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Morton Brown Family Wealth's REGN Position: Q2 2026 in Review

Morton Brown Family Wealth opened a new position in Regeneron Pharmaceuticals (REGN) in Q2 2026: 1 share worth $624. The stake represents ﹤0.01% of the portfolio and ranks #348 among its holdings. This is a return to the name: Morton Brown Family Wealth previously reported a position in REGN as recently as Q1 2023.

Morton Brown Family Wealth first reported a position in REGN in Q1 2023 and has held it in 2 quarters since. The position peaked at $2.46K in Q1 2023. 334 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Morton Brown Family Wealth held 1 share of Regeneron Pharmaceuticals worth $624 as of Q2 2026.
  • Regeneron Pharmaceuticals was a new Morton Brown Family Wealth position in Q2 2026.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Morton Brown Family Wealth's portfolio in Q2 2026, its #348 holding.
  • Morton Brown Family Wealth first reported a position in Regeneron Pharmaceuticals in Q1 2023 and has held it in 2 quarters since.
  • Morton Brown Family Wealth's Regeneron Pharmaceuticals position peaked at $2.46K in Q1 2023.
  • 334 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Morton Brown Family Wealth's 13F filing for Q2 2026, filed 21 Jul 2026.